- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1420-9071
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Signaling pathways and mesenchymal transition in pediatric high-grade glioma ; day:21 ; month:11 ; year:2017 ; pages:1-17
Cellular and molecular life sciences ; (21.11.2017), 1-17
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Meel, Michaël H.
- Contributor
-
Schaper, Sophie A.
Kaspers, Gertjan J. L.
Hulleman, Esther
SpringerLink (Online service)
- DOI
-
10.1007/s00018-017-2714-7
- URN
-
urn:nbn:de:1111-201801241474
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Meel, Michaël H.
- Schaper, Sophie A.
- Kaspers, Gertjan J. L.
- Hulleman, Esther
- SpringerLink (Online service)
Other Objects (12)
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Clinical significance of FBXO17 gene expression in high-grade glioma
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma
Benefits of supportive strategies for carers of people with high-grade glioma: a systematic review : Strategies for addressing the needs of high-grade glioma carers
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Clinical significance of FBXO17 gene expression in high-grade glioma
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma
Benefits of supportive strategies for carers of people with high-grade glioma: a systematic review : Strategies for addressing the needs of high-grade glioma carers
Pediatric Non–Brain Stem High-Grade Glioma: A Single-Center Experience
Pediatric high-grade glioma MYCN is frequently associated with Li-Fraumeni syndrome
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Computational multi-omics analysis of pediatric DADDR patients and synthetic lethality prediction in K27M mutated pediatric high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Clinical significance of FBXO17 gene expression in high-grade glioma
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma